These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7076296)

  • 21. Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits.
    Reed WP; Jaffee P; Albright EL; Williams RC
    Infect Immun; 1980 Sep; 29(3):1021-7. PubMed ID: 7429626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific IgG subclass antibody levels and phagocytosis of serotype 14 pneumococcus following immunization.
    Kaniuk AS; Lortan JE; Monteil MA
    Scand J Immunol Suppl; 1992; 11():96-8. PubMed ID: 1514059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
    Campos IB; Herd M; Moffitt KL; Lu YJ; Darrieux M; Malley R; Leite LC; Gonçalves VM
    Vaccine; 2017 Mar; 35(9):1306-1315. PubMed ID: 28161422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal killing in the alveolus. Evidence for a nonphagocytic defense mechanism for early clearance.
    Coonrod JD; Rehm SR; Yoneda K
    Chest; 1983 May; 83(5 Suppl):89S-90S. PubMed ID: 6687709
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunomodulatory Effects of Pneumococcal Extracellular Vesicles on Cellular and Humoral Host Defenses.
    Codemo M; Muschiol S; Iovino F; Nannapaneni P; Plant L; Wai SN; Henriques-Normark B
    mBio; 2018 Apr; 9(2):. PubMed ID: 29636428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opsonizing antibodies against pneumococci detected by enhanced NBT. Reduction of phagocytizing granulocytes.
    Urban T; Jarstrand C; Tunevall G
    Infection; 1982; 10(5):271-6. PubMed ID: 7174111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.
    Schweinle JE
    Infect Immun; 1986 Dec; 54(3):876-81. PubMed ID: 3781629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.
    Jansen WT; Gootjes J; Zelle M; Madore DV; Verhoef J; Snippe H; Verheul AF
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):703-10. PubMed ID: 9729539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement facilitates macrophage phagocytosis of inhaled iron particles but has little effect in mediating silica-induced lung inflammatory and clearance responses.
    Warheit DB; Carakostas MC; Bamberger JR; Hartsky MA
    Environ Res; 1991 Dec; 56(2):186-203. PubMed ID: 1663034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The critical role of complement in experimental pneumococcal sepsis.
    Hosea SW; Brown EJ; Frank MM
    J Infect Dis; 1980 Dec; 142(6):903-9. PubMed ID: 7462698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : II. THE EFFECT OF SULFONAMIDE THERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.
    Wood WB; Irons EN
    J Exp Med; 1946 Sep; 84(4):365-76. PubMed ID: 19871575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3.
    Fine DP; Kirk JL; Schiffman G; Schweinle JE; Guckian JC
    J Lab Clin Med; 1988 Oct; 112(4):487-97. PubMed ID: 3171357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
    Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
    Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.
    Li J; Szalai AJ; Hollingshead SK; Nahm MH; Briles DE
    Infect Immun; 2009 Jan; 77(1):464-71. PubMed ID: 19001076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein reactivity with complement and effects on phagocytosis.
    Mold C; Du Clos TW; Nakayama S; Edwards KM; Gewurz H
    Ann N Y Acad Sci; 1982; 389():251-62. PubMed ID: 7046579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing.
    Aberdein JD; Cole J; Bewley MA; Marriott HM; Dockrell DH
    Clin Exp Immunol; 2013 Nov; 174(2):193-202. PubMed ID: 23841514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency
    Ugrinovic S; Firth H; Kavanagh D; Gouliouris T; Gurugama P; Baxendale H; Lachmann PJ; Kumararatne D; Gkrania-Klotsas E
    Clin Exp Immunol; 2020 Dec; 202(3):379-383. PubMed ID: 32640035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumococcal antibodies and complement during and after periods of recurrent otitis.
    Prellner K; Kalm O; Pedersen FK
    Int J Pediatr Otorhinolaryngol; 1984 Mar; 7(1):39-49. PubMed ID: 6724809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.
    Johnston RB; Klemperer MR; Alper CA; Rosen FS
    J Exp Med; 1969 Jun; 129(6):1275-90. PubMed ID: 4181833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.